S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.48
+1.80
+10.79%
KYNB · Kyntra Bio, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$5.20
+0.27
(+5.48%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$5.20
$5.20
$5.20
52-WEEK RANGE
$5.20
$4.85
$11.65
What's happening
- KYNB is up 5.48% today, trading at $5.20. — Live quote
- Volume today (100) is well below its 3-month average of 23,390. (Finnhub fundamentals)
- Reports earnings on 2026-11-09 (after market close), 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-4.69 actual vs. $-3.25 estimated (-44.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 5
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
KYNB
-39.86%
vs S&P 500
-52.64%
1-YEAR RETURN
KYNB
-52.58%
vs S&P 500
-67.14%
6-MONTH RETURN
KYNB
-26.56%
3-MONTH RETURN
KYNB
-27.67%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-4.69
Est. $-3.25
MISS -44.5%
2026-04-26 (Q1 2026)
$-3.76
Est. $-3.42
MISS -9.9%
2026-01-26 (Q4 2025)
$-3.61
Est. $-3.96
BEAT +8.9%
2025-10-26 (Q3 2025)
$-3.25
Est. $-4.09
BEAT +20.4%
Valuation Measures & Ratios
Enterprise Value4-$29.3M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)4.63
Price / Book70.81
EV4 / Revenue-3.93
EV4 / EBITDA—
Profit Margin2199.42%
Operating Margin-690.63%
Return on Equity (ROE8)-290.91%
Return on Assets (ROA9)156.80%
Avg Volume (3M)23,390
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $29.9M | $27.3M | $49.1M | $21.0M | $31.0M |
| P/E | 0.16 | 0.15 | 0.27 | -0.59 | -0.51 |
| Price/Sales | 6.38 | 3.07 | 9.28 | 4.04 | 1.06 |
| Price/Book | -0.99 | -0.62 | -2.88 | -0.09 | -0.14 |
| EV/Revenue | -4.43 | -1.09 | -13.03 | -0.44 | -0.09 |
| ROE | -629.67% | -416.58% | -1060.54% | 15.96% | 28.09% |
| ROA | 187.78% | 166.45% | 131.80% | -19.99% | -36.87% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short100,040
Change from Prior Settlement-0.67%
% of Float—
Days to Cover (Short Ratio)3.74
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Net profit margin is 2199.4%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-06; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -48.4% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is -52.6%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on KYNB
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -$1.5M | $3.7M | $1.1M | $1.3M | $2.7M | $123.0K | $998.0K | $25.4M |
| Operating income | -$17.6M | -$13.8M | -$5.4M | -$12.1M | -$14.9M | -$47.7M | -$46.4M | -$49.2M |
| Net income | $12.0M | -$15.2M | $200.6M | -$7.6M | $4.6M | -$17.1M | -$15.5M | -$32.9M |
| EPS (diluted) | $2.96 | $-3.76 | $49.61 | $-1.88 | $1.15 | $-4.25 | $-3.89 | $-0.33 |
| EPS (basic) | $2.96 | $-3.76 | $49.61 | $-1.88 | $1.15 | $-4.25 | $-3.89 | $-0.33 |
| Operating margin | $1.2K | -$370 | -$503 | -$894 | -$545 | -$38.8K | -$4.7K | -$194 |
| Net margin | -$812 | -$407 | $18.6K | -$564 | $169 | -$13.9K | -$1.6K | -$130 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Aug '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $101.1M | $109.6M | $119.6M | $137.0M | — | $178.1M | $165.2M | $214.5M |
| Total liabilities | $109.2M | $118.9M | $115.1M | $119.5M | — | $359.1M | $340.1M | $398.2M |
| Stockholders' equity | -$30.1M | -$43.8M | -$30.0M | -$17.0M | — | -$223.0M | -$216.9M | -$225.6M |
| Total current assets | $96.8M | $101.4M | $99.1M | $133.4M | — | $162.3M | $148.5M | $196.5M |
| Total current liabilities | $36.0M | $28.1M | $29.2M | $36.0M | — | $155.9M | $73.4M | $133.3M |
| Cash & equivalents | $50.6M | $37.0M | $47.9M | $118.0M | — | $23.4M | $33.6M | $50.5M |
| Marketable securities (current) | $40.7M | $50.2M | $41.1M | — | — | — | — | $0 |
| Accounts receivable | $347.0K | $5.0M | $216.0K | $121.0K | — | $136.0K | $147.0K | $481.0K |
| Inventory | $3.4M | $3.4M | $3.7M | $3.9M | — | $3.9M | $3.2M | $3.2M |
| Other current assets | $833.0K | $556.0K | $1.1M | $695.0K | — | $1.3M | $1.3M | $1.1M |
| Marketable securities (non-current) | $4.0M | $8.0M | $20.2M | $3.0M | — | — | — | $0 |
| Property, plant & equipment | — | — | — | — | — | — | — | $0 |
| Other non-current assets | $241.0K | $248.0K | $361.0K | $556.0K | — | $839.0K | $1.1M | $1.4M |
| Accounts payable | $7.5M | $5.1M | $3.7M | $5.1M | — | $10.5M | $7.3M | $5.1M |
| Accrued liabilities | $23.1M | $17.3M | $20.2M | $25.8M | — | $35.9M | $35.3M | $62.0M |
| Deferred revenue (current) | $5.4M | $5.7M | $5.3M | $5.1M | — | $27.3M | $22.5M | $27.3M |
| Long-term debt | — | — | — | — | $75.0M | — | — | — |
| Other non-current liabilities | $67.0K | $76.0K | $82.0K | $98.0K | — | $106.0K | $830.0K | $822.0K |
| Common stock & paid-in capital | $41.0K | $40.0K | $1.0M | $1.0M | — | $1.0M | $1.0M | $1.0M |
| Retained earnings | -$1.71B | -$1.72B | -$1.71B | -$1.69B | — | -$1.89B | -$1.88B | -$1.89B |
| Accumulated other comprehensive income (loss) | -$1.2M | -$1.9M | -$2.2M | -$2.2M | — | -$4.8M | -$4.4M | -$5.7M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.0M | -$13.9M | -$18.3M | -$1.8M | $12.7M | $2.7M | -$30.5M | -$8.4M |
| Investing cash flow | $17.7M | $3.0M | -$51.7M | $87.2M | -$13.0K | -$16.0K | $1.7M | $755.0K |
| Financing cash flow | -$5.0K | -$7.0K | -$14.0K | -$85.9M | -$9.0K | -$88.0K | $5.0K | -$127.0K |
| Free cash flow | -$4.0M | -$13.9M | -$18.3M | -$1.9M | $12.7M | $2.7M | -$30.6M | -$8.5M |
| Capital expenditures | $0 | $0 | $0 | $9.0K | $13.0K | $16.0K | $141.0K | $82.0K |
| Share-based compensation | $984.0K | $1.2M | $1.2M | $662.0K | $1.9M | $2.9M | $178.0K | $7.7M |
| Deferred income taxes | — | — | $0 | — | — | — | $0 | — |
| Change in accounts receivable | -$4.7M | $4.8M | $94.0K | -$552.0K | -$159.0K | $3.2M | -$9.2M | $21.9M |
| Change in inventory | $0 | -$359.0K | -$122.0K | -$1.0M | -$1.4M | -$2.9M | -$4.5M | -$2.2M |
| Change in accounts payable | $2.4M | $1.3M | -$1.3M | -$4.6M | $3.1M | -$24.8M | $23.2M | -$728.0K |
| Purchases of investments | $3.9M | $11.1M | $58.1M | $3.0M | $0 | $0 | $0 | $0 |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $5.0K | $7.0K | $8.0K | $12.0K | $12.0K | $37.0K | $14.0K | $111.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $6.4M | $29.6M | $46.8M | $140.7M | $235.3M |
| Operating income | -$45.9M | -$150.4M | -$322.7M | -$301.0M | -$288.5M |
| Net income | $183.5M | -$47.6M | -$284.2M | -$293.7M | -$290.0M |
| EPS (diluted) | $45.37 | $-11.89 | $-2.92 | $-3.14 | $-3.14 |
| EPS (basic) | $45.37 | $-11.89 | $-2.92 | $-3.14 | $-3.14 |
| Operating margin | -$713 | -$508 | -$690 | -$214 | -$123 |
| Net margin | $2.8K | -$161 | -$607 | -$209 | -$123 |
Balance sheet
| Line item | Dec '25 | Aug '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| Total assets | $119.6M | — | $214.5M | $423.5M | $610.1M |
| Total liabilities | $115.1M | — | $398.2M | $585.7M | $611.6M |
| Stockholders' equity | -$30.0M | — | -$225.6M | -$204.2M | -$21.4M |
| Total current assets | $99.1M | — | $196.5M | $331.6M | $492.8M |
| Total current liabilities | $29.2M | — | $133.3M | $217.7M | $273.6M |
| Cash & equivalents | $47.9M | — | $50.5M | $81.6M | $155.7M |
| Marketable securities (current) | $41.1M | — | $0 | $121.9M | $266.3M |
| Accounts receivable | $216.0K | — | $481.0K | $5.1M | $16.3M |
| Inventory | $3.7M | — | $3.2M | $17.2M | $40.4M |
| Other current assets | $1.1M | — | $1.1M | $6.7M | $4.4M |
| Marketable securities (non-current) | $20.2M | — | $0 | — | — |
| Property, plant & equipment | — | — | $0 | $4.8M | $20.6M |
| Other non-current assets | $361.0K | — | $1.4M | $2.5M | $5.3M |
| Accounts payable | $3.7M | — | $5.1M | $15.8M | $30.8M |
| Accrued liabilities | $20.2M | — | $62.0M | $133.0M | $219.8M |
| Deferred revenue (current) | $5.3M | — | $27.3M | $12.7M | $12.7M |
| Long-term debt | — | $75.0M | — | — | — |
| Other non-current liabilities | $82.0K | — | $822.0K | $2.9M | $6.4M |
| Common stock & paid-in capital | $1.0M | — | $1.0M | $988.0K | $942.0K |
| Retained earnings | -$1.71B | — | -$1.89B | -$1.84B | -$1.56B |
| Accumulated other comprehensive income (loss) | -$2.2M | — | -$5.7M | -$6.9M | -$5.7M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$4.8M | -$138.0M | -$315.0M | -$145.9M | -$82.2M |
| Investing cash flow | $35.4M | $126.0M | $153.7M | $89.1M | -$427.0M |
| Financing cash flow | -$86.0M | -$255.0K | $122.7M | $46.8M | -$563.0K |
| Free cash flow | -$4.8M | -$138.3M | -$317.5M | -$149.7M | -$87.4M |
| Capital expenditures | $38.0K | $266.0K | $2.5M | $3.7M | $5.2M |
| Share-based compensation | $6.6M | $25.2M | $50.8M | $65.6M | $71.2M |
| Deferred income taxes | $0 | $0 | $0 | $0 | $0 |
| Change in accounts receivable | $2.5M | $6.7M | -$3.4M | -$765.0K | -$25.2M |
| Change in inventory | -$5.4M | -$22.3M | $1.7M | $11.0M | $14.2M |
| Change in accounts payable | -$27.7M | $14.5M | -$15.5M | $5.9M | $805.0K |
| Purchases of investments | $61.2M | $8.6M | $251.8M | $164.0M | $484.1M |
| Sales/maturities of investments | — | — | — | — | — |
| Tax withholding on stock comp | $69.0K | $354.0K | $237.0K | $5.2M | $7.4M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding KYNB as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-03-24 to 2026-09-06
Recent transactions
- Insiders have net bought 2,800 shares over the last 182 days, across 1 purchase and 0 sales.
- Most recent: Wettig Thane (CEO) — Tax withholding of 209 shares on 2026-09-06.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)2,800 sh(1 txns)
Sales (open market)0 sh(0 txns)
Net Shares+2,800
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Wettig Thane | CEO | Tax withholding | 2026-09-06 | 209 |
| DeLucia David | Chief Financial Officer | Tax withholding | 2026-09-06 | 22 |
| Schoeneck James A | Reporting person | Open market purchase | 2025-06-30 | 23,567 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-06 | Wettig Thane | CEO | Tax withholding | 209 | $8.55 |
| 2026-09-06 | DeLucia David | Chief Financial Officer | Tax withholding | 22 | $8.55 |
| 2026-06-06 | Wettig Thane | CEO | Tax withholding | 198 | $6.71 |
| 2026-06-06 | DeLucia David | Chief Financial Officer | Tax withholding | 52 | $6.71 |
| 2026-05-14 | Wettig Thane | CEO | Open market purchase | 2,800 | $7.09 |
| 2026-03-06 | Wettig Thane | CEO | Tax withholding | 277 | $6.84 |
| 2026-03-06 | DeLucia David | Chief Financial Officer | Tax withholding | 60 | $6.84 |
| 2025-12-06 | DeLucia David | Chief Financial Officer | Tax withholding | 52 | $8.42 |
| 2025-12-06 | Wettig Thane | CEO | Tax withholding | 259 | $8.42 |
| 2025-11-17 | Wettig Thane | CEO | Open market purchase | 2,700 | $9.10 |
| 2025-11-13 | Wettig Thane | CEO | Open market purchase | 1,000 | $9.18 |
| 2025-09-06 | DeLucia David | Chief Financial Officer | Tax withholding | 53 | $12.10 |
| 2025-09-06 | Wettig Thane | CEO | Tax withholding | 248 | $12.10 |
| 2025-06-30 | Schoeneck James A | Reporting person | Open market purchase | 23,567 | $5.07 |
| 2025-06-06 | DeLucia David | Chief Financial Officer | Tax withholding | 51 | $7.83 |
| 2025-06-06 | Wettig Thane | CEO | Tax withholding | 246 | $7.83 |
| 2025-03-24 | Wettig Thane | CEO | Open market purchase | 145,000 | $0.35 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:36 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-06 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-06 | 8-K | 2026-09-30 | View on SEC.gov → |
| 2026-10-01 | 8-K | 2026-09-30 | View on SEC.gov → |
| 2026-09-09 | 4 | 2026-09-06 | View on SEC.gov → |
| 2026-09-09 | 4 | 2026-09-06 | View on SEC.gov → |
| 2026-08-31 | 8-K | 2026-08-31 | View on SEC.gov → |
| 2026-08-13 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-13 | 8-K | 2026-08-13 | View on SEC.gov → |
| 2026-06-17 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-06-17 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-06-17 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-06-17 | 4 | 2026-06-12 | View on SEC.gov → |
Recent news
Headlines about KYNB (Kyntra Bio, Inc.). Links open the publisher — we don’t host full articles.
-
Kyntra Bio stock gains 16.83 percent to EUR 4.72 at Lang & Schwarz - ad-hoc-news.de
ad-hoc-news.de · 2026-10-20 -
(KYNB) Volatility Zones as Tactical Triggers
Stock Traders Daily · 2026-10-18 -
Kyntra Bio stock fell to USD 4.85 on October 16, down 9.5 percent
AD HOC NEWS · 2026-10-17 -
Kyntra Bio stock costs EUR 5.00 at a USD 22.6 million market value
AD HOC NEWS · 2026-10-15 -
Maxim Group Initiates Coverage On Kyntra Bio with Buy Rating, Announces Price Target of $35
Benzinga · 2026-10-13 -
Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
Yahoo Finance · 2026-10-01 -
Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance · 2026-09-02 -
Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation
Yahoo Finance · 2026-08-31
No headlines in this category right now — try “All”.